Seres Therapeutics, Inc.
Why Seres TherapeuticsAt Seres Therapeutics, we have a singular mission to transform the lives of patients by targeting the underlying cause of their diseases. We are pioneers and explorers, charting a new course. You’ll have the opportunity to truly define your area of focus.If you have a pioneering spirit, join us as we ignite a revolution in the treatment of disease through the microbiome.What’s Your Mission?Reporting to the Director of Formulation Development, this role will be critical in designing and developing novel, oral dosage forms to provide safe and efficacious delivery of Seres’ microbiome drugs for a range of indications. Working with a creative, collaborative team, you will select dosage forms, design formulations, define processes and develop a mechanistic understanding of how formulation and process variables impact product performance. You will also enable pioneering unit operations and enteric technologies through feasibility assessments and recommendations to senior management.What You’ll DoDevelop drug products based on QTPPs using formulation screening and experimental design (DoE), risk assessments and process understandingPartner with Analytical Development team to develop characterization and release methodsCollaborate with Manufacturing Engineering Technology team to optimize processes for small scale, pilot scale, and commercial scale manufacturingPerform feasibility assessments of new process and analytical technologies (light travel req’d) What You’ll BringStrong team player with excellent communication skills working in a cross-functional matrixAbility to work independently and take initiativeIntellectual curiosity and resilience in solving complex problemsCourage to take risks and follow through to completionPhD in pharmaceutical science, chemical engineering, biomedical engineering, or related field with 0-2 years of experience, or MS with 2-4 years of experience, or BS with 5-8 years of experienceYou May Also BringGood working knowledge in the field of microbiologyExperience working collaboratively with CMOs (Contract Manufacturing Organizations)Who We AreSeres Therapeutics is a clinical stage biotherapeutic company focused on discovering and developing Ecobiotic™ therapeutic products, novel drugs to treat important diseases by targeting the underlying biology of the human microbiome. Founded by Flagship VentureLabs, Seres is pioneering the first therapeutics that catalyze a shift to health by augmenting the biology of the microbiome. Current candidates span infectious, metabolic, and inflammatory diseases. For more information, please visit
Seres Therapeutics, Inc.
Website : http://www.serestherapeutics.com
Seres Therapeutics is creating a new class of medicines to treat diseases resulting from functional deficiencies in the microbiome, a condition known as dysbiosis New insights into the human microbiome are fundamentally reshaping how we understand and treat a wide range of diseases, creating new possibilities for patients not served by current approaches. We are a clinical biopharmaceutical company with a powerful platform to discover and develop drugs to treat diseases in multiple areas of medicine that arise from dysbiosis. Our team of drug development experts discovers and designs new medicines using our proprietary microbiome therapeutics platform. We pinpoint functional differences between a healthy and dysbiotic microbiome, and rationally design potential Ecobiotic® drugs. These therapeutics are ecological compositions made up of beneficial organisms that are designed to target functional deficiencies and reestablish keystone features of a healthy microbiome. Our discovery efforts currently span metabolic, inflammatory, and infectious diseases.